Founders Financial Alliance’s Genmab GMAB Stock Holding History

Founders Financial Alliance’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-122	Closed	-$5K	–	765
2020 Q3	$5K	Buy	+122	New	+$4.41K	﹤0.01%	971

Other funds holding GMAB

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Founders Financial Alliance's GMAB Position: Q4 2020 in Review

Founders Financial Alliance sold out of Genmab (GMAB) in Q4 2020, closing a stake of 122 shares — an estimated $5K sold.

Founders Financial Alliance first reported a position in GMAB in Q3 2020 and held it in 1 quarter. The position peaked at $5K in Q3 2020. 227 funds tracked by Wall St. Rank hold GMAB as of Q4 2020.

Founders Financial Alliance reported no remaining Genmab position as of Q4 2020 after selling out during the quarter.
Founders Financial Alliance sold 122 Genmab shares in Q4 2020, an estimated $5K.
Founders Financial Alliance first reported a position in Genmab in Q3 2020 and held it in 1 quarter.
Founders Financial Alliance's Genmab position peaked at $5K in Q3 2020.
227 funds tracked by Wall St. Rank held Genmab as of Q4 2020.

Based on Founders Financial Alliance's 13F filing for Q4 2020, filed 4 Feb 2021.